Letter to the Editor From Greenman et al: "Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study"

Yona Greenman*, Naomi Even-Zohar, Karen Tordjman

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)E3094
JournalJournal of Clinical Endocrinology and Metabolism
Volume107
Issue number7
DOIs
StatePublished - 1 Jul 2022

Keywords

  • anti-androgen
  • cyproterone acetate
  • transgender

Cite this